Jiangli Ban

Association of Vitamin D Deficiency With Abnormal Electrocardiographic Activity Among Healthy People

Corrigendum to “A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice” [Biochem. Biophys. Res. Commun. 621 (2022) 122–129]

Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2

Effect of High‑Fat-Diet and Semaglutide on Bladder Cancer in Mice

The Relationship Between Non-HDL-C /HDL-C Ratio (NHHR) and Vitamin D in Type 2 Diabetes Mellitus

Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice

Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics

Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study

Association Between Vitamin D Levels and the Atherogenic Index of Plasma Among Chinese with Type 2 Diabetes Mellitus

Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis

Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis

Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice

UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice

A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice

Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study